M & A M A R K E T M O N I T O...

6
M&A MARKET MONITOR HEALTHCARE SERVICES APRIL 2019

Transcript of M & A M A R K E T M O N I T O...

M&A MARKETMONITORHEALTHCARE SERVICES APRIL 2019

5 Yr

4 Yr

3 Yr

2 Yr

1 Yr

PP

About the DataThe information presented in this report is an analysis of deals in the United States or Canada. A deal is described as any closed or announced M&A transaction where the target is headquartered in the United States or Canada, financial terms of the transaction have been disclosed, and the target has an industry classification that falls into the subject industry group and as such may not be representative of your company's market valuation. Past performance is not indicative of future results. Certain adjustments have been made to the information

to exclude transactions which are not specific to the industry or incorporate relevant transactions for which an industry classification was omitted.

US & Canada M&A Market OverviewOverall Market Transactions

Source: S&P Capital IQ; ArkMalibu; Other publicly available sources

*YTD as of 03/31/2019

22,926 20,858

18,487 19,455

5,196

11.1x 10.7x12.0x

11.2x10.5x

-

5,000

10,000

15,000

20,000

25,000

2.0x

4.0x

6.0x

8.0x

10.0x

12.0x

14.0x

16.0x

18.0x

2015 2016 2017 2018 2019 YTD*

Dea

l C

oun

t

Med

ian

TE

V/ L

TM

EB

ITD

A

Mult

iple

Deal Count Median TEV/ LTM EBITDA Multiple

Healthcare Services

5 Yr

4 Yr

3 Yr

2 Yr

1 Yr

About the DataThe information presented in this report is an analysis of deals in the United States or Canada. A deal is described as any closed or announced M&A transaction where the target is headquartered in the United States or Canada, financial terms of the transaction have been disclosed, and the target has an industry classification that falls into the subject industry group and as such may not be representative of your company's market valuation. Past performance is not indicative of future results. Certain adjustments have been made to the information

to exclude transactions which are not specific to the industry or incorporate relevant transactions for which an industry classification was omitted.

Source: S&P Capital IQ; ArkMalibu; Other publicly available sources

*YTD as of 03/31/2019

US & Canada M&A Market OverviewHealthcare Services Transactions

644 589 595 595

145

11.4x

15.5x

10.3x9.6x

8.4x

-

100

200

300

400

500

600

700

2015 2016 2017 2018 2019 YTD*

0.0x

2.0x

4.0x

6.0x

8.0x

10.0x

12.0x

14.0x

16.0x

18.0x

Dea

l C

oun

t

Med

ian

TE

V/ L

TM

EB

ITD

A

Mult

iple

Deal Count Median TEV/ LTM EBITDA Multiple

Public Companies' Trading Metrics | Healthcare ServicesAs of: 3/31/2019

USD in millions except per share price

Last Equity Enterprise EBITDA

Price Value Value Margin 2017A LTM NTM 2017A LTMLast Sale PriceMarket CapitalizationTotal Enterprise ValueLTM EBITDA Margin %CY - 1 TEV/Total RevenuesLTM TEV/Total RevenuesNTM TEV/Forward Total RevenueCY - 1 TEV/EBITDALTM TEV/EBITDANTM TEV/Forward EBITDA

Acute-Care Hospitals

Community Health Systems, Inc. 3.73 421 14,399 10.3% 0.9 1.0 1.1 8.7 9.8

HCA Healthcare, Inc. 130.38 44,787 79,091 19.1% 1.5 1.7 1.6 8.0 8.8

LHC Group, Inc. 110.86 3,482 3,798 9.1% 1.3 2.1 1.8 13.8 23.1

Tenet Healthcare Corporation 28.84 2,969 19,610 15.2% 1.0 1.1 1.1 8.6 6.7

Median 69.85 3,225 17,004 12.7% 1.1 1.4 1.3 8.7 9.3

Assisted Living

Brookdale Senior Living Inc. 6.58 1,228 5,329 15.2% 1.7 1.5 1.3 9.8 10.1

Capital Senior Living Corporation 3.99 125 1,116 13.4% 3.0 2.4 2.4 17.5 18.2

Median 5.29 676 3,223 14.3% 2.4 2.0 1.8 13.6 14.2

Behavioral Health

AAC Holdings, Inc. 1.84 45 350 9.8% 1.5 1.1 1.2 11.6 11.2

Acadia Healthcare Company, Inc. 29.31 2,592 5,764 19.0% 2.2 1.9 1.8 10.6 10.1

Magellan Health, Inc. 65.92 1,577 2,200 2.0% 0.5 0.3 0.3 10.6 14.8

Universal Health Services, Inc. 133.77 12,142 16,112 15.6% 1.4 1.5 1.4 8.7 9.6

Median 47.62 2,085 3,982 12.7% 1.5 1.3 1.3 10.6 10.6

Diagnostic Imaging

RadNet, Inc. 12.39 620 1,352 10.9% 1.2 1.4 1.3 8.7 11.5

Varian Medical Systems, Inc. 141.72 12,865 12,214 18.8% 3.7 4.1 3.9 20.3 21.7

Median 77.06 6,743 6,783 14.9% 2.4 2.7 2.6 14.5 16.6

Dialysis Services

Centene Corporation 53.10 21,940 23,485 4.6% 0.4 0.4 0.3 8.0 8.9

Molina Healthcare, Inc. 141.96 8,891 7,523 6.9% 0.1 0.4 0.5 18.2 6.0

WellCare Health Plans, Inc. 269.75 13,569 12,042 4.5% 0.3 0.6 0.5 7.3 13.2

Median 141.96 13,569 12,042 4.6% 0.3 0.4 0.5 8.0 8.9

Category / Company Valuation Statistics Multiples Data

EV / Revenue (x) EV / EBITDA (x)

NTM

8.7

8.2

17.5

7.3

9.4

8.4

8.7

8.5

8.5

13.1

13.7

13.4

7.4

8.4

19.2

13.8

7.4

7.5

10.4

7.5

to exclude transactions which are not specific to the industry or incorporate relevant transactions for which an industry classification was omitted.

Source: SP Capital IQ; ArkMalibu;

EV = enterprise value; LTM = last twelve months; NTM = next twelve months

NM = Not Meaningful

Public Companies' Trading Metrics | Healthcare ServicesAs of: 3/31/2019

USD in millions except per share price

Last Equity Enterprise EBITDA

Price Value Value Margin 2017A LTM NTM 2017A LTM

Category / Company Valuation Statistics Multiples Data

EV / Revenue (x) EV / EBITDA (x)

NTM

to exclude transactions which are not specific to the industry or incorporate relevant transactions for which an industry classification was omitted.

Home Care

Addus HomeCare Corporation 63.59 828 775 7.6% 1.0 1.5 1.3 11.7 19.8

Amedisys, Inc. 123.26 3,946 3,934 10.1% 1.2 2.4 2.0 15.0 22.3

Chemed Corporation 320.07 5,111 5,195 15.6% 2.4 2.9 2.7 16.5 18.7

LHC Group, Inc. 110.86 3,482 3,798 9.1% 1.3 2.1 1.8 13.8 23.1

Median 117.06 3,714 3,866 9.6% 1.3 2.2 1.9 14.4 21.1

Home Infusion

BioScrip, Inc. 2.00 256 840 5.8% 1.0 1.2 1.1 25.3 20.5

Median 2.00 256 840 5.8% 1.0 1.2 1.1 25.3 20.5

Long-Term Care

National HealthCare Corporation 75.88 1,158 1,053 10.3% 0.9 1.1 NM 7.9 10.3

The Ensign Group, Inc. 51.19 2,698 2,912 9.0% 0.8 1.4 1.3 10.7 15.9

Median 63.54 1,928 1,983 9.7% 0.8 1.3 1.3 9.3 13.1

Rehabilitation

Encompass Health Corporation 58.40 5,767 8,754 20.6% 2.0 2.0 1.9 9.4 9.8

Select Medical Holdings Corporation 14.09 1,906 5,943 12.2% 1.3 1.2 1.1 11.3 9.2

U.S. Physical Therapy, Inc. 105.03 1,340 1,492 15.6% 2.7 3.3 3.1 17.1 21.3

Median 58.40 1,906 5,943 15.6% 2.0 2.0 1.9 11.3 9.8

Specialty Practice Management

MEDNAX, Inc. 27.17 2,333 4,249 15.3% 2.0 1.2 1.1 11.2 7.5

Median 27.17 2,333 4,249 15.3% 2.0 1.2 1.1 11.2 7.5

Surgery Centers

Surgery Partners, Inc. 11.28 550 4,230 18.2% 3.3 2.4 2.3 18.4 12.8

Median 11.28 550 4,230 18.2% 3.3 2.4 2.3 18.4 12.8

15.3

19.0

16.0

17.5

16.7

12.3

12.3

NM

12.6

12.6

9.3

8.8

21.7

9.3

7.6

7.6

15.9

15.9

Source: SP Capital IQ; ArkMalibu;

EV = enterprise value; LTM = last twelve months; NTM = next twelve months

NM = Not Meaningful

ABOUTArkMalibu advises business owners by making highly informed and relevant recommendations on steps towards finding a great partner or monetizing their businesses. We help you maximize value by effectively conveying your company’s investment merits and minimizing the buyers’ perceived investment risks. As one of the most trusted boutique investment banking firms, we leverage our proprietary process to serve our privately-owned clients based on our experience, creativity, and avoidance of conflicts of interest. We focus our energy and talent on turning culture into capital so that we can creatively deliver value beyond our clients’ expectations.

Sell-Side Focused• ArkMalibu’s unique business model is to focus solely

on sell-side clients• Experienced and expert negotiators motivated to

meet all your goals• No conflicts of interest – other investment banks often

find themselves negotiating against their regular clients on the buyside

Art of the Possible• ArkMalibu has a strong track record of achieving

maximum value for our clients• Creativity to explore less obvious avenues for meeting

our client’s goals and achieving maximum value

Four Boxes Methodology• Proprietary process minimizes buyers’ perceived risks

and unlocks value for your company• Focus on your corporate culture fit

Client Focus• Active senior banker involvement• Financial advocates – effectively execute the client’s

chosen deal strategy• Financial confidants – confidentiality is of utmost

importance

Experienced Team• Our team has decades of M&A experience• Decades of operations, leadership, and strategic